131 related articles for article (PubMed ID: 37289419)
1. An Insight on Synergistic Anti-cancer Efficacy of Biochanin A and Sulforaphane Combination Against Breast Cancer.
Li J; Xu J; Sun Y; Fu R; Ye D
Appl Biochem Biotechnol; 2024 Feb; 196(2):992-1007. PubMed ID: 37289419
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.
Hussain A; Mohsin J; Prabhu SA; Begum S; Nusri Qel-A; Harish G; Javed E; Khan MA; Sharma C
Asian Pac J Cancer Prev; 2013; 14(10):5855-60. PubMed ID: 24289589
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
6. D,L-sulforaphane-induced apoptosis in human breast cancer cells is regulated by the adapter protein p66Shc.
Sakao K; Singh SV
J Cell Biochem; 2012 Feb; 113(2):599-610. PubMed ID: 21956685
[TBL] [Abstract][Full Text] [Related]
7. Cauliflower bioactive compound sulforaphane inhibits breast cancer development by suppressing NF-κB /MMP-9 signaling pathway expression.
Zhou T; Zhou M; Tong C; Zhuo M
Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):134-143. PubMed ID: 35988280
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.
Lu Z; Zhang Y; Xu Y; Wei H; Zhao W; Wang P; Li Y; Hou G
Mol Biol Rep; 2022 Jan; 49(1):451-461. PubMed ID: 34731371
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762
[TBL] [Abstract][Full Text] [Related]
11. d,l-Sulforaphane Induces ROS-Dependent Apoptosis in Human Gliomablastoma Cells by Inactivating STAT3 Signaling Pathway.
Miao Z; Yu F; Ren Y; Yang J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054986
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
[TBL] [Abstract][Full Text] [Related]
13. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
Jin CY; Molagoda IMN; Karunarathne WAHM; Kang SH; Park C; Kim GY; Choi YH
Toxicol Appl Pharmacol; 2018 Aug; 352():132-141. PubMed ID: 29792947
[TBL] [Abstract][Full Text] [Related]
14. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2‑UDP glucuronosyltransferase 1A metabolic axis activation.
Hao Q; Wang M; Sun NX; Zhu C; Lin YM; Li C; Liu F; Zhu WW
Oncol Rep; 2020 Apr; 43(4):1067-1080. PubMed ID: 32323779
[TBL] [Abstract][Full Text] [Related]
16. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
Bose C; Awasthi S; Sharma R; Beneš H; Hauer-Jensen M; Boerma M; Singh SP
PLoS One; 2018; 13(3):e0193918. PubMed ID: 29518137
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells.
Wang Y; Wu H; Dong N; Su X; Duan M; Wei Y; Wei J; Liu G; Peng Q; Zhao Y
Sci Rep; 2021 Jan; 11(1):2504. PubMed ID: 33510228
[TBL] [Abstract][Full Text] [Related]
20. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]